Seeing purple: University scientist on tackling pancreatic cancer
Pancreatic cancer is an unusual cancer as it does not react to chemotherapy in the same way as others do.
This is why academics from the University of Leicester, working with colleagues at Leicester’s hospitals and in Cambridge, have started two drug trials in the city. They hope to combine new drugs with existing chemotherapy to improve treatment.
Our Head of Cancer Studies and Molecular Medicine, Professor Will Steward, is involved in the trials and spoke to the Leicester Mercury this week about the problems researchers face in combating what is a poorly understood disease.